Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherr

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
Journal of Diabetes Science and Technology|October 4, 2021
Continuous Ketone Monitoring Consensus Report 2021Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Hormone Research in Paediatrics|December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia|December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Diabetes|January 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 DiabetesCarla J Greenbaum, S Alice Long, Stephen E Gitelman, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Journal of Diabetes Science and Technology|October 4, 2021
Continuous Ketone Monitoring Consensus Report 2021Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Hormone Research in Paediatrics|December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia|December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Diabetes|January 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 DiabetesCarla J Greenbaum, S Alice Long, Stephen E Gitelman, et al.
Pageof 25